BTI
British American Tobacco p.l.c.
There isn't enough reported data to score BTI yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BTI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Unavailable |
BTI's profitability is currently strong. There isn't enough data to rate its revenue, cash flow and balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BTI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $43.57 | -29% |
| Fair | 12x | $57.21 | -6.3% |
| Current | 16x | $61.04 | — |
| Expensive | 23x | $108 | +76% |
Historical ranges are pointers, not guarantees.
BTI's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over BTI in the historical PE scenario, which offers more potential upside but is not a forecast.
BTI Forward outlook
There aren't enough analyst estimates for BTI to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $4.64 | +156% |
| Q2 2025 | $1.85 | +$10.13 |
| Q4 2024 | $1.81 | +$10.41 |
| Q2 2024 | -$8.28 | -261% |
| Q4 2023 | -$8.60 | -322% |
| Q2 2023 | $5.15 | +65% |
| Q4 2022 | $3.88 | -1.3% |
BTI has returned to profit: it earned $4.64 per share over the past year, after losing money the year before.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BTI in the latest year-over-year earnings comparison.
BTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $16.4B | +2.1% |
| Q4 2025 | $18B | +0.1% |
| Q2 2025 | $16.1B | -2.2% |
| Q4 2024 | $18B | -2.3% |
| Q2 2024 | $16.4B | -8.2% |
| Q4 2023 | $18.4B | -6.4% |
| Q2 2023 | $17.9B | +4.4% |
| Q4 2022 | $19.7B | +9.5% |
BTI's revenue has slid since its 2022 peak: $16.4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 38% | +3.7 points |
| Q4 2025 | 36% | +193 points |
| Q2 2025 | 42% | -2.2 points |
| Q4 2024 | -11% | -58 points |
| Q2 2024 | 35% | +5.9 points |
| Q4 2023 | -157% | -196 points |
| Q2 2023 | 44% | +3.9 points |
| Q4 2022 | 46% | +10 points |
BTI has the edge over CELH on profitability, with a higher operating margin.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BTI in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
BTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.3B | +12% |
| Q4 2025 | $4.8B | -46% |
| Q2 2025 | $2.9B | -28% |
| Q4 2024 | $8.8B | -5.7% |
| Q2 2024 | $4.1B | -6.6% |
| Q4 2023 | $9.3B | +3.6% |
| Q2 2023 | $4.3B | +4.6% |
| Q4 2022 | $9B | -4.5% |
BTI's free cash flow has been positive every quarter for seven years: $19.8B over the past year, down 26% from the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -23M shares |
| 1 year | -2.5% | -56M shares |
| 3 years | -5.1% | -118M shares |
| 5 years | -3.9% | -88.7M shares |
| Available history | -3.9% | -88.7M shares |
BTI has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1B |
| Q4 2025 | $1.4B |
| Q2 2025 | $81.1M |
| Q4 2024 | $804.8M |
| Q2 2024 | $123.7M |
| Q4 2023 | $146.3M |
| Q2 2023 | $146.3M |
| Q4 2022 | $2.6B |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BTI Net Leverage
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 76.3 | Neutral |
BTI's weekly RSI is 56 (neutral) and its Stochastic is 76 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BTI PE vs Consumer Defensive Sector
| Metric | BTI | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 19x | 19% below |
| PE % | 80 | 18 | 62 pts above |
BTI has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.3 | 4.6% above |
| 20 week MA | $58.4 | 4.5% above |
| 50 week MA | $59.0 | 3.4% above |
| 100 week MA | $53.0 | 15% above |
| 200 week MA | $43.1 | 42% above |
BTI has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.5 | $37.3 | -12% |
| 2021 | $37.3 | $37.1 | -0.5% |
| 2022 | $37.1 | $40.6 | +9.5% |
| 2023 | $40.6 | $29.3 | -28% |
| 2024 | $29.3 | $36.3 | +24% |
| 2025 | $36.3 | $57.3 | +58% |
| 2026 YTD | $57.3 | $61.0 | +6.6% |
BTI has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.